Emergency Medicine

HIV / AIDS

Medical News

Primary Care

Surgery

Home » Archive by Category

Articles in the Lupus Category

Genomes Of Identical Twins Reveal Epigenetic Changes That May Play Role In Lupus
Monday, 28 Dec, 2009 – 0:00 | No Comment

Identical twins look the same and are nearly genetically identical, but environmental factors and the resulting cellular changes could cause disease in one sibling and not the other. In a study published online in Genome Research (www.genome.org), scientists have studied twins discordant for the autoimmune disease lupus, mapping DNA modifications across the genome and shedding light on epigenetic changes that may play a role in the disease…

Link Discovered Between The Nervous And Immune Systems - Might Lead To New Treatments For Autoimmune Disorders
Tuesday, 1 Dec, 2009 – 6:00 | No Comment

If you ever thought the stress of seeing your extended family over the holidays was slowly killing you - bad news: a new research report in the December 2009 print issue of the Journal of Leukocyte Biology shows that you might be right. Here’s the good news: results from the same study might lead to entirely new treatments that help keep autoimmune diseases like lupus, arthritis, and eczema under control…

ImmuPharma Announces Final Results Of PhaseIIb Study Of LUPUZOR™ In Lupus
Monday, 23 Nov, 2009 – 3:00 | No Comment

ImmuPharma PLC announced the final results from a Phase IIb trial of LUPUZOR™ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor™ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.

Promise Of A New Lupus Treatment Is A Groundbreaking Achievement
Tuesday, 3 Nov, 2009 – 7:00 | No Comment

Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA™ (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology.

BENLYSTA™ Successful In Second Pivotal Clinical Trial
Tuesday, 3 Nov, 2009 – 0:00 | No Comment

Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA™ (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology.

Lupus Patients Who Receive Kidney Transplants Rarely Develop Lupus Nephritis
Monday, 2 Nov, 2009 – 3:00 | No Comment

Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a paper being presented at the American Society of Nephrology’s 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

Kidney Transplants Generally Safe For Lupus Patients, New Study Suggests
Friday, 30 Oct, 2009 – 21:00 | No Comment

Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a new article. The findings indicate that having lupus should not keep individuals from seeking a kidney transplant if they need one. Contrary to previous studies, a new study suggests lupus patients who receive kidney transplants rarely develop lupus nephritis.

ACR: Depression and CVD Linked in Patients with Lupus (CME/CE)
Friday, 23 Oct, 2009 – 6:00 | No Comment

PHILADELPHIA (MedPage Today) — For patients with systemic lupus erythematosus, depression further increases their already elevated risk for cardiovascular disease, researchers reported here.

ACR: Bug Sprays Linked to RA (CME/CE)
Thursday, 22 Oct, 2009 – 10:29 | No Comment

PHILADELPHIA (MedPage Today) — Women who frequently sprayed their homes with insecticides over a period of years may have put themselves at risk for autoimmune diseases such as rheumatoid arthritis and lupus, a researcher said here.

Cellular Mechanism That Causes Lupuslike Symptoms In Mice Identified By Stanford Study
Monday, 19 Oct, 2009 – 4:00 | No Comment

Macrophages, the scavenger cells of the body’s immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease.